Article info
Original research
Long-term stability of 0.1% rapamycin hydrophilic gel in the treatment of facial angiofibromas
- Correspondence to Dr. Guillaume Le Guyader, Pharmacy Department, Henri Mondor Hospital Group, Créteil 94010, France; leguyader.guillaume{at}gmail.com
Citation
Long-term stability of 0.1% rapamycin hydrophilic gel in the treatment of facial angiofibromas
Publication history
- Received July 25, 2018
- Revised October 4, 2018
- Accepted October 9, 2018
- First published November 10, 2018.
Online issue publication
March 26, 2020
Article Versions
- Previous version (10 November 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© European Association of Hospital Pharmacists 2020. No commercial re-use. See rights and permissions. Published by BMJ.